Stress and cardiac beta adrenoceptors

Stress

Volumn 9, Issue 2, 2006, Pages 69-84

  Santos, Iraídes N ^a   Spadari Bratfisch, Regina C ^a,b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Adaptive responses; Beta adrenoceptors; Cardiac function; Stress

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; 4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; 4 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL]PHENOXYACETIC ACID; 5 [2 [[2 HYDROXY 3 [4 (1 METHYL 4 TRIFLUOROMETHYL 2 IMIDAZOLYL)PHENOXY]PROPYL]AMINO]ETHOXY]SALICYLAMIDE; ADRENALIN; ANTHRACYCLINE DERIVATIVE; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA 4 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM ION; CARMOTEROL; CYCLIC AMP DEPENDENT PROTEIN KINASE; DOXORUBICIN; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE TRIPHOSPHATE; ISOPRENALINE; METOPROLOL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PERTUSSIS TOXIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROPRANOLOL; REACTIVE OXYGEN METABOLITE; RECEPTOR SUBTYPE; SALBUTAMOL; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ADRENERGIC SYSTEM; APOPTOSIS; ARTICLE; CARDIOTOXICITY; ENZYME ACTIVATION; HEART FAILURE; HEART FUNCTION; HEART HYPERTROPHY; HEART MUSCLE CELL; HUMAN; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STRESS;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; HEART; MODELS, BIOLOGICAL; RECEPTORS, ADRENERGIC, BETA; STRESS;

EID: 33747097832     PISSN: 10253890     EISSN: 16078888     Source Type: Journal    
DOI: 10.1080/10253890600771858     Document Type: Article

References (152)

1. Axelrod J, Reisine TD. 1984. Stress hormones: Their interaction and regulation. Science 224:452-459.
2. 2 adrenoceptors. J Pharmacol Exp Ther 246:316-321.
3. Beavo JA. 1995. Cyclic nucleotide phosphodiesterases: Functional implications of multiple isoforms. Physiol Rev 75:725-748.
4. Bernstein D, Fajardo G, Zhao M, Urashima T, Powers J, Berry G, Kobilka BK. 2005. Differential cardioprotective/cardiotoxic effects mediated by β-adrenergic receptor subtypes. Am J Physiol 289:H2441-H2449, (Heart Circ. Physiol).
5. Bers DM. 2001. Excitation-contraction coupling and cardiac contractile force. 2nd ed. Dordretch: Kluwer Academic Press.
6. 1-adrenergic receptor in transgenic mice. J Mol Cell Cardiol 32:817-830.
7. Bohm M, Gierschik P, Jakobs KH, Pieske B, Schnabel P, Ungerer M, Erdmann E. 1990. Increase of Gi α in human hearts with dilated but not ischemic cardiomyopathy. Circulation 82: 1249-1265.
8. Bohm M, Eschenhagen T, Gierschik P, Larisch K, Lensche H, Mende U, Schmitz W, Schnabel P, Scholz H, Steinfath M. 1994. Radioimmunochemical quantification of Giα in right atria and left ventricles from patients with ischaemic and dilated cardiomyopathy and predominant left ventricular failure. J Mol Cell Cardiol 26:133-149.
9. 2-adrenoceptors in sheep cardiac ventricular muscle. J Mol Cell Cardiol 24:753-764.
10. Bossuyt J, Ai X, Moorman JR, Pogwizd SM, Bers DM. 2005. Expression and phosphorylation of the Na-pump regulatory subunit phospholemman in heart failure. Circ Res 97:558-565.
11. 1-receptor downregulation in heart failure. Circ Res 59:297-309.
12. 2-adrenoceptors in the human heart: Properties, function, and alterations in chronic heart failure. Pharmacol Rev 43:203-242.
13. Brodde OE, Michel MC. 1999. Adenergic and muscarinic receptors in the human heart. Pharmacol Rev 51:651-681.
14. Callia ML, De Moraes S. 1984. Heterogeneity of beta adrenoceptors in right atria isolated from cold-exposed rats. J Pharmacol Exp Ther 230:450-454.
15. Cannon WB. 1939. The wisdom of the body. New York: W.W. Norton.
16. Carr AN, Schmidt AG, Suzuki Y. 2002. Type I phosphatase, a negative regulator of cardiac function. Mol Cell Biol 22: 4124-4135.
17. Chakraborti S, Chakraborti T, Shaw G. 2000. β-adrenergic mechanism in cardiac diseases: A perspective. Cell Signal 12: 499-513.
18. 3-adrenoceptor studies using a monoclonal antibody. Int J Obes 23:1057-1065.
19. Charmandari E, Tsigos C, Chrousos G. 2005. Endocrinology of the stress response. Annu Rev Physiol 67:259-284.
20. Charmock JS. 1994. Lipids and cardiac arrhythmias. Prog Lipid Res 33:355-385.
21. +2 channels. Biophys J 79: 2547-2556.
22. Chrousos GP, Gold PW. 1992. The concepts of stress and stress system disorders. Overview of physical and behavioural homeostasis. J Am Med Assoc 267:1244-1252.
23. γ-dimers in transmembrane signalling. Nature 365:403-406.
24. Clerk A, Michael A, Sugden PH. 1998. Stimulation of multiple mitogen-activated protein kinase subfamilies by oxidative stress and phophorylation of the small heat shock protein, HSP25 27, in neonatal ventricular myocytes. Biochem J 333:581-589.
25. Communal C, Singh K, Pimentel DR, Colucci WS. 1998. Noradrenaline stimulates apoptosis in adult rat ventricular myocytes by activation of β-adrenergic pathway. Circulation 98:1329-1334.
26. 2-adrenergic receptors on cardiac myocyte apoptosis: Role of pertusis toxin-sensitive G protein. Circulation 100:2210-2212.
27. 2-adrenergic receptor to different G proteins by protein kinase A. Nature 390:88-91.
28. Dalla AK, Hill MF, Singal PK. 1996. Role of oxidative stress in transition of hypertrophy to heart failure. J Am Coll Cardiol 28:506-514.
29. Davis AM, Natelson BH. 1993. Brain-heart interactions. The neurocardiology of arrhythmia and sudden cardiac death. Tex Heart Inst J 20:158-169.
30. 3-adrenoceptors in rat hearts. Diabetes 50:455-461.
31. 2-adrenergic receptors differentially affect cardiac hypertrophy and function in Gαq- overexpressing mice. Proc Natl Acad Sci U S A 96:6400-6405.
32. 1-adrenergic receptor transgenic mice. Proc Natl Acad Sci U S A 96:7059-7064.
33. iα2 in human end-stage heart failure. Circ Res 70:688-696.
34. Evans BA, Papaioannou M, Bonazzi VR, Summers RJ. 1996. Expression of beta 3-adrenoceptor mRNA in rat tissues. Br J Pharmacol 117:1210-1216.
35. Fabiato A, Fabiato F. 1979. Calcium and cardiac excitation-contraction coupling. Annu Rev Physiol 41:473-484.
36. Farias-Silva E, Grassi-Kassisse DM, Wolf-Nunes V, Spadari-Bratfisch RC. 1999. Stress-induced alteration in the lipolytic response to β-adrenoceptor agonists in rat white adipocytes. J Lipid Res 40:1719-1727.
37. Farias-Silva E, Santos IN, Amaral MEC, Grassi-Kassisse DM, Spadari-Bratfisch RC. 2004. Glucocorticoid receptor and beta-adrenoceptor expression in epididymal adipose tissue from stressed rats. Ann N Y Acad Sci 1018:1-5.
38. Feldman MD, Copelas L, Gwathmey JK, Phillips P, Warren SE, Schoen FJ, Grossman W, Morgan JP. 1987. Deficient production of cyclic AMP: Pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure. Circulation 75:331-339.
39. 2+ transients in mouse ventricular myocytes. Naunyn-Schmiedeberg's Arch Pharmacol 360:445-456.
40. Frielle T, Daniel KW, Caron M, Lefkowitz RJ. 1988. Structural basis of beta-adrenergic receptor subtype specificity studied with chimeric beta1/beta2-adrenergic receptors. Proc Natl Acad Sci USA 85:9494-9498.
41. 3-adrenoceptors in human heart. J Clin Invest 98:556-562.
42. 3- adrenoceptors in the cardiovascular system. Trends Pharmacol Sci 21:426-431.
43. Gether U, Kobilka B. 1998. G protein-coupled receptors, II: Mechanism of agonist activation. J Biol Chem 273: 17979-17982.
44. Giacobino JP. 1995. Beta 3-adrenoceptor: An update. Eur J Endocrinol 132:377-385.
45. Girouard H, Chulak C, LeJossec M, Lamontagne D, de Champlain J. 2003. Chronic antioxidant treatment improves sympathetic functions and β-adrenergic pathway in the spontaneously hypertensive rats. J Hypertens 21:179-188.
46. Goldstein DS. 2001. The autonomic nervous system in health and disease. New York: Marcel Dekker.
47. Goldstein DS. 2003. Catecholamines and stress. Endocr Regul 37:69-89.
48. Goldstein DS, McEwen B. 2002. Allostasis, homeostats, and the nature of stress. Stress 5:55-58.
49. 1-adrenergic receptor. Am J Physiol Endocrinol Metab 43:E199-E202.
50. Gu XH, Kompa AR, Summers RJ. 1998. Regulation of β-adrenoceptors in a rat model of heart failure: Effects of perindopril. J Cardiovasc Pharmacol 32:66-74.
51. Gudbjarnason S, Benedikdótirr VW. 1996. Regulation of β adrenoceptor properties and the lipid milieu in heart muscle membranes during stress. Mol Cell Biochem 163/164:137-143.
52. Haft JI. 1974. Cardiovascular injury induced by sympathetic catecholamines. Prog Cardiovasc Dis 17:73-86.
53. 2-adrenoceptors in human atrial myocardium. Circ Res 66:1610-1623.
54. Hamm HE. 1998. The many faces of G protein signaling. J Biol Chem 273:669-672.
55. Hemingway H, Marmot M. 1999. Evidence based cardiology: Psychosocial factors in the etiology and prognosis of coronary heart disease. Systematic review of prospective cohort studies. BMJ 318(7196):1460-1467.
56. 3-adrenoceptor function in murine heart. Br J Pharmacol 136:217-229.
57. Horenstein MS, Vander HRS, L'Ecuyer TJ. 2000. Molecular basis of anthracycline-induced cardiotoxicity and its prevention. Mol Genet Metab 71:436-444.
58. Iwai-Kanai E, Hasegawa K, Araki M, Kakita T, Morimoto T, Sasayama S, Iwai-Kanai E, Hasegawa K, Araki M. 1999. α and β-adrenergic pathways differentially regulate cell type-specific apoptosis in rat cardiac myocytes. Circulation 100:305-311.
59. 2-adrenergic stimulation. Circ Res 91:46-53.
60. 2-adrenoceptors activated by (-)-adrenaline in rat sinoatrial node. Naunyn-Schmiedeberg's Arch Pharmac 332:406-409.
61. Kaumann AJ. 1989. Is there a third heart β-adrenoceptor? Trends Pharmacol Sci 10:316-320.
62. Kaumann AJ. 1997. Four β-adrenoceptor subtypes in mammalian heart. Trends Pharmacol Sci 18:70-76.
63. Kaumann AJ, Lynham JA. 1997. Stimulation of cyclic AMP-dependent protein kinase in rat atria by (-)-CGP 12177 through an atypical β-adrenoceptor. Br J Pharmacol 120:1187-1189.
64. Kaumann AJ, Molenaar P. 1997. Modulation of human cardiac function through 4 beta-adrenoceptor populations. Naunyn-Schmiedeberg's Arch Pharmacol 355:677-681.
65. Kaumann AJ, Hall JA, Murray KJ, Wells FC, Brown MJ. 1989a. A comparison of the effects of adrenaline and noradrenaline on human heart: The role of beta 1- and beta 2-adrenoceptors in the stimulation of adenylate cyclase and contractile force. Eur Heart J 10:29-37.
66. Kaumann AJ, Hall JA, Murray KJ, Wells FC, Brown MJ. 1989b. A comparison of the effects of adrenaline and noradrenaline on human heart: The role of adenylate cyclase and contractile force. Eur Heart J 10(Supp B):29-37.
67. 2-adrenoceptor activation by zinterol causes protein phosphorylation, contractile effects and relaxant effects through a cAMP pathway in human atrium. Mol Cell Biochem 163/164:113-123.
68. 1 adrenoceptors hastens relaxation and mediates phosphorilation of phospholambam, troponin I and C protein in ventricular myocardium from patients with terminal heart failure. Circulation 99:65-72.
69. 4-adrenoceptor pharmacology. Naunyn-Schmiedeberg's Arch Pharmacol 363:87-93.
70. 2-adrenergic and several other G protein-coupled receptors in human atrial membranes activate both Gs and Gi. Circ Res 87:705-709.
71. Kinugawa S, Tsutsui H, Hayashidani S, Ide T, Suematsu N, Satoh S, Utsumi H, Takeshita A. 2000. Treatment with dimethylthiourea prevents left ventricular remodeling and failure after experimental myocardial infarction in mice: Role of oxidative stress. Circ Res 87:392-398.
72. Kiuchi K, Shannon RP, Komamura K, Cohen DJ, Bianchi C, Homcy Ci, J, Vatner SF, Vatner DE. 1993. Myocardial β-adrenergic receptor function during the development of pacing-induce heart failure. J Clin Invest 91:904-907.
73. Koss KL, Kranias EG. 1996. Phospholamban: A prominent regulator of myocardial contractility. Circ Res 79:1059-1063.
74. 1-adrenoceptors, relax the rat isolated mesenteric artery. Br J Pharmacol 140:3-12.
75. 3-adrenergic receptor mRNA in man. J Clin Invest 91:344-349.
76. 2-adrenergic signaling. J Biol Chem 274:22048-22052.
77. 2-adrenergic cAMP signaling is uncoupled from phosphorylation of cytoplasmic proteins in canine heart. Circulation 99:2458-2465.
78. Kvetnansky R, Mikulaj M. 1970. Adrenal and urinary catecholamines in rats during adaptation to repeated immobilization stress. Endocrinology 87:738-743.
79. Kvetnansky R, McCarty R, Thoa NB, Lake CR, Kopin IJ. 1979. Sympatho-adrenal responses of spontaneously hypertensive rats to immobilization stress. Am J Physiol 236:H457-H462, (Heart Circ. Physiol. 5).
80. 3-adrenergic receptors expressed in native fat cells and in transfected cell lines. Cell Signal 6:363-392.
81. Lefkowitz RJ, Cotecchia S, Samama P, Costa T. 1993. Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends Pharmacol Sci 14:303-307.
82. Lemoine H, Kaumann AJ. 1991. Regional differences of beta 1- and beta 2-adrenoceptor-mediated functions in feline heart a beta 2-adrenoceptor-mediated positive inotropic effect possibly unrelated to cyclic AMP. Naunyn-Schmiedeberg's Arch Pharmacol 344:56-69.
83. Levine S. 2005. PSYCDE XX:1-8.
84. 1- adrenoceptor in ferret ventricular myocardium. Br J Pharmacol 135:451-461.
85. Mann DL, Kent RL, Parsons B, Cooper 4th, G. 1992. Adrenergic effects on the biology of the adult mammalian cardiocyte. Circulation 85:790-804.
86. Marcondes FK, Vanderlei LCM, Lanza LLB, Spadari-Bratfisch RC. 1996. Stress-induced subsensitivity to catecholamines depends on the estrous cycle. Can J Physiol Pharmacol 74: 663-699.
87. McEwen B, Stellar E. 1993. Stress and the individual mechanisms leading of disease. Arch Intern Med 153:2093-2101.
88. +2 release channels and their regulation by endogenous effectors. Annu Rev Physiol 56:485-508.
89. Mende U, Eschenhage T, Geertz B, Schimitz W, Scholz H, Schulte AM, Esch J, Sempell R, Steinfathe M. 1992. Isoprenaline-induced increase in the 40/41 kDa pertussis toxin substrates and functional consequences on contractile response in rat heart. Naunyn-Schmiedeberg's Arch Pharmacol 345:44-50.
90. 2+ current is regulated by cyclic GMP-dependent protein kinase in mammalian cardiac myocytes. Proc Natl Acad Sci U S A 288:1197-1201.
91. 2-adrenergic receptor. Science 264:582-586.
92. 4-adrenoceptor in mammalian heart. Clin Exp Pharmacol Physiol 24:647-656.
93. 1- adrenergic receptors to Gs-protein. Circulation 102:1814-1821.
94. 3-adrenoceptors and altered contractile response to inotropic amines in human failing heart. Circulation 103:1649-1655.
95. 3-adrenoceptor activation contributes to left ventricular and cardiomyocyte dysfunction in heart failure. Am J Physiol Heart Circ Physiol 286:H2425-H2433.
96. Moura MJCS, De Moraes S. 1994. Forced swim stress: Supersensitivity of the isolated rat pacemaker to the chronotropic effect of isoprenaline and the role of corticosterone. Gen Pharmacol 25:1341-1347.
97. 2 receptors, propranolol-resistant binding sites and on some subsequent steps in intracellular signaling. Naunyn-Schmiedeberg's Arch Pharmacol 368:366-376.
98. Myslivecek J, Ricny J, Palkovits M, Kvetnansky R. 2004. The effects of short-term immobilization stress on muscarinic receptors, β-adrenoceptors, and adenylyl cyclase in different heart regions. Ann N Y Acad Sci 1018:315-322.
99. Myslivecek J, Nováková M, Palkovits M, Krizanová O, Kvetnansky R. 2006. Distribution of mRNA and binding sites of adrenoceptors and muscarinic receptors in the rat heart. Life Sci, in press.
100. Natelson BH, Tapp WN, Adamus JE, Mittler JC, Levin BE. 1981. Humoral indices of stress in rats. Physiol Behav 26:1049-1054.
101. Natelson BH, Ottenweller JE, Cook JA, Pitman D, McCarty R, Tapp WN. 1988. Effect of stressor intensity on habituation of the adrenocortical stress response. Physiol Behav 43:41-46.
102. Neer EJ. 1995. Heterotrimeric G proteins: Organizers of transmembrane signaling. Cell 80:249-257.
103. Nishizawa T, Iwase M, Kanazawa H, Ichihara S, Ichihara G, Nagata K, Obata K, Kitaichi K, Yokoi T, Watanabe M, Tsunematsu T, Ishikawa Y, Murohara T, Yokota M. 2004. Serial alterations of β-adrenergic signaling in dilated cardiomyopathic hamsters-possible role of myocardial oxidative stress. Circ J 68: 1051-1060.
104. Nourani FRR, Spadari RC, De Moraes S. 1992. Footshock stress-induced supersensitivity to isoprenaline in the isolated pacemaker of the rat: Effects of the compounds RU-38486 and RU-8362. Gen Pharmacol 23:787-791.
105. 3- adrenoceptor function. Naunyn-Schmiedeberg's Arch Pharmacol 361: 134-145.
106. Ostman-Smith I. 1979. Adaptive changes in the sympathetic nervous system and some effector organs of the rat following long term exercise or cold acclimation and the role of cardiac sympathetic nerves in the genesis of compensatory cardiac hypertrophy. Acta Physiol Scand Suppl 477:1-118.
107. Pacák K, Palkovits M. 2001. Stressor specificity of central neuroendocrine responses: Implications for stress-related disorders. Endocr Rev 22:502-548.
108. Pacák K, Palkovits M, Yadid G, Kvetnansky R, Kopin IJ, Goldstein DS. 1998. Heterogeneous neurochemical responses to different stressors: A test of Selye's doctrine of nonspecificity. Am J Physiol 275:R1247-R1255, (Regulatory Integrative Comp. Physiol. 44).
109. Parker JD, Landzberg JS, Bittl JA, Mirsky I, Collucci WS. 1991. Effects of beta-adrenergic stimulation with dobutamine on isovolumic relaxation in the normal and failing human left ventricle. Circulation 84:1040-1048.
110. Pott C, Brixius K, Bundkirchen A, Bolck B, Bloch W, Steinritz D, Mehlhorn U, Schwinger RH. 2003. The preferential beta3-adrenoceptor agonist BRL 37344 increases force via beta1-/beta2-adrenoceptors and induces endothelial nitric oxide synthase via beta3-adrenoceptors in human atrial myocardium. Br J Pharmacol 138:521-529.
111. Rasmusen IM, Schou HS, Hermansen K. 1989. Cardiotoxic effects and the influence on the β-adrenoceptor function of doxorubicin (adriamycin) in the rat. Pharmacol Toxicol 65:69-72.
112. Ray K, Hansen cA, Robishaw JD. 1996. Gβγ-mediated signalling in the heart: Implications of β an γ subunit heterogeneity. Trends Cardiovasc Med 6:115-121.
113. Remondino A, Kwon SH, Communal C, Pimentel DR, Sawyer DB, Singh K, et al. 2003. β-adrenergic receptor-stimulated apoptosis in cardiac myocytes is mediated by reactive oxygen species c-Jun NH2-terminal kinase-dependent activation of the mitochondrial pathway. Circ Res 92:136-138.
114. Reuter H. 1983. Calcium channel modulation by neurotransmitters, enzymes and drugs. Nature 301:569-574.
115. 1-adrenergic receptor gene. Proc Natl Acad Sci U S A 93:7375-7380.
116. Sabban EL, Kvetnansky R. 2001. Stress-triggered activation of gene expression in catecholaminergic systems: Dynamics of transcriptional events. Trends Neurosci 24:91-98.
117. Sano M, Fukuda K, Sato T, Kawaguchi H, Suematsu M, Matsuda S, Koyasu S, Matsui H, Yamauchi-Takihara K, Harada M, Saito Y, Ogawa S. 2001. ERK and p38 MAPK, but not NF-kappaB, are critically involved in reactive oxygen species-mediated induction of IL-6 by angiotensi II in cardiac fibroblasts. Circ Res 89:661-669.
118. Santos IN, Spadari-Bratfisch RC. 2001. Chronotropic response to (±)-CGP12177 in right atria of stressed rats. Can J Physiol Pharmacol 79:393-399.
119. 1-adrenoceptor site activated by CGP12177 varies in behavior according to the estrous cycle phase and stress. Can J Physiol Pharmacol 81:459-468.
120. Santos IN, Sumitame M, Caceres VM, Moreira MF, Krieger MH, Spadari-Bratfisch RC. 2005. Evidence for two atypical conformations of beta-adrenoceptors and their interaction with Gi proteins. Eur J Pharmacol 513:109-118.
121. Sapolsky RM, Romero LM, Munck AU. 2000. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocrinol Rev 21:55-89.
122. 3H}-CGP12177 binding. Br J Pharmacol 128:1445-1460.
123. 1-adrenoceptor. Naunyn-Schmiedeberg's Arch Pharmacol 367:10-21.
124. Sartiani L, De Paoli P, Stillitano F, Aimond F, Vassort G, Mugelli A, Gerbai E. 2006. Functional remodeling in port-myocardial infarcted rats: Focus on beta-adrenoceptor subtypes. J Mol Cell Cardiol 40:258-266.
125. Sawyer DB, Siwik DA, Xiao L, Pimentel DR, Singh K, Colucci WS. 2002. Role of oxidative stress in myocardial hypertrophy and failure. J Mol Cell Cardiol 34:379-388.
126. Selye H. 1936. A syndrome produced by diverse nocuous agents. Nature 138:32.
127. Selye H. 1956. The stress of life. New York: McGraw-Hill Book Inc.. p 324.
128. Senba E, Ueyama T. 1997. Stress-induced expression of immediately early genes in the brain and peripheral organs of the rat. Neurosci Res 29:183-207.
129. Spadari-Bratfisch RC, De Moraes S. 1988. Repeated swimming stress and responsiveness of isolated rat pacemaker to chronotropic effect of noradrenaline and isoprenaline: Role of adrenal corticosteroids. Gen Pharmacol 19:553-557.
130. Spadari-Bratfisch RC, Bassani RA, De Moraes S. 1988. Supersensitivity to isoprenaline and epinephrine in right atria isolated from rats submitted to a single swimming session. Gen Pharmac 19(1):129-135.
131. 2-adrenoceptors in right atria from stressed female rats. Can J Physiol Pharmacol 77:432-440.
132. Stanton HC, Brenner G, Mayfield Jr, E. 1969. Studies on isoproterenol-induced cardiomegaly in rats. Am Heart J 77:72-80.
133. Sterling P, Eyer J. 1988. Allostasis: A new paradigm to explain arousal pathology. In: Fisher S, Reason J, editors. Handbook of life stress, cognition and health. New York: Wiley. p 629-649.
134. Stubbs CD, Smith AD. 1994. The modification of mammalian membrane poly-unsaturated fatty acid composition in relation to membrane fluidity and function. Biochim Biophys Acta 779:89-137.
135. Takahashi K, Fujita Y, Mayumi T, Hama T, Kishi T. 1987. Effect of adriamycin on cultured mouse embryo myocardial cells. Chem Pharm Bull (Tokyo) 35:326-334.
136. Torda T, Kvetnansky R, Petrikova M. 1984. Effect of repeated immobilization stress on rat central and peripheral adrenoceptors. In: Usdin E, Kvetnansky R, Axelrod J, editors. Stress: The role of catecholamines and other neurotransmitters. 2. New York: Gordon and Breach Science Publishers. p 691-701.
137. U'Prichard DC, Kvetnansky R. 1980. Central and peripheral adrenergic receptor in acute and repeated immobilization stress. In: Usdin E, Kvetnansky R, Kopin IJ, editors. Catecholamines and stress: Recent advances. Basel, Switzerland: Elsevier/North Holland, Inc.. p 299-308.
138. Ueyama T, Umemoto S, Senba E. 1996. Immobilization stress induced c-fos and c-jun immediate early genes expression in the heart. Life Sci 59:339-347.
139. Ueyama T, Yoshida K-I, Senba E. 1999. Emotional stress induces immediate-early gene expression in the rat heart via activation of α- and β-adrenoceptors. Am J Physiol 277:H1553-H1561, Heart Circ. Physiol. 46.
140. Vanderlei LCM, Marcondes FK, Lanza LLB, Spadari-Bratfisch RC. 1996. Influence of the estrous cycle in the sensitivity to catecholamines in right atria from rats submitted to foot-shock stress. Can J Physiol Pharmacol 74:670-678.
141. Wahler GM, Dollinger SJ. 1995. Nitric oxide donor SIN-1 inhibits mammalian cardiac calcium current through cGMP-dependent protein kinase. Am J Physiol 268:C45-C54.
142. 1 adrenergic receptor modulates receptor trafficking and signaling in cardiac myocytes. J Biochem Chem 277: 33783-33790.
143. 2-adrenoceptor to a pertussis toxin-sensitive G protein in cardiac myocytes. Mol Pharmacol 47:322-329.
144. 2-adrenergic responses without changes in inhibitory G proteins or receptor kinases. J Clin Invest 101:1273-1282.
145. i proteins and its physiological relevance in murine cardiac myocytes. Circ Res 84:43-52.
146. Zanesco A, Spadari-Bratfisch RC, Barker AL. 1997. Sino-aortic denervation causes right atrial beta adrenoceptor down-regulation. J Pharmacol exp Ther 280:677-685.
147. Zaugg M, Xu W, Lucchinetti E, Shafiq SA, Jamali NZ, Siddiqui MA. 2000. β-adrenergic receptor subtypes differentially affect apoptosis in adult rat ventricular myocytes. Circulation 102:344-350.
148. Zhang G-X, Kimura S, Nishiyama A, Shokoji T, Rahman M, Yao L, Nagai Y, Fujisawa Y, Miyatake A, Abe Y. 2005. Cardiac oxidative stress in acute and chronic ioproterenol-infused rats. Cardiovasc Res 65:230-238.
149. Zhu WZ, ZouY, Aikawa R, Harada K, Kudoh S, Uozumi H, Hayashi D, Gu Y, Yamazaki T, Nagai R, Yazaki Y, Komuro I. 1999. MAPK superfamily plays an important role in daunomycin-induced apoptosis of cardiac myocytes. Circulation 100:2100-2107.
150. 2-adrenergic signaling in adult mouse cardiac myocytes. Proc Natl Acad Sci U S A 98:1607-1612.
151. +2/Calmodulin kinase II. J Clin Invest 111:617-625.
152. Zou Y, Komuro I, Yamazaki T, Kudoh S, Uozumi H, Kadowaki T, Yazaki Y. 1999b. Both Gs and Gi proteins are critically involved in isoproterenol-induced cardiomyocyte hypertrophy. J Biol Chem 274:9760-9770.